NutriBand (NTRB) Change in Accured Expenses (2016 - 2026)
NutriBand (NTRB) posted Change in Accured Expenses of $136539.0 for Q2 2026, up 233.24% sequentially from -$102473.0 in Q1 2026, and up 497.54% YoY from $22850.0 in Q2 2025.
NutriBand (NTRB) Change in Accured Expenses (2016 - 2026) Analysis & Trends
NutriBand has reported Change in Accured Expenses for 11 years, with the latest figure at $136539.0 in Q2 2026.
- Quarterly Change in Accured Expenses rose 497.54% year-over-year to $136539.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $234632.0 (up 187.71% YoY) and the FY2026 annual result came in at $120943.0, up 412.23% from the prior year.
- Change in Accured Expenses improved to $136539.0 in Q2 2026 per NTRB's latest filing, from -$102473.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $671189.0 in Q3 2025 and troughed at -$470623.0 in Q4 2025.
- A 5-year average of $20681.2 and a median of -$2013.5 in 2022 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses soared 29851.29% in 2024, then plunged 515.28% in 2025.
- Over 5 years, Change in Accured Expenses stood at -$85020.0 in 2022, then slipped by 28.11% to -$108916.0 in 2023, then surged by 204.05% to $113327.0 in 2024, then slumped by 515.28% to -$470623.0 in 2025, then jumped by 129.01% to $136539.0 in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $136539.0, -$102473.0, and -$470623.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 212.44 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 61.62 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 68.82 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 136,539.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 136,539.00 |
| Apr 30, 2026 | 136,539.00 |
| Jan 31, 2026 | -102,473.00 |
| Jan 31, 2026 | -102,473.00 |
| Oct 31, 2025 | -470,623.00 |
| Oct 31, 2025 | -470,623.00 |
| Jul 31, 2025 | 671,189.00 |
| Jul 31, 2025 | 671,189.00 |
| Apr 30, 2025 | 22,850.00 |
| Apr 30, 2025 | 22,850.00 |
| Jan 31, 2025 | -193,333.00 |
| Jan 31, 2025 | -193,333.00 |
| Oct 31, 2024 | 113,327.00 |
| Oct 31, 2024 | 113,327.00 |
| Jul 31, 2024 | -210,357.00 |
| Jul 31, 2024 | -210,357.00 |
| Apr 30, 2024 | 313,974.00 |
| Apr 30, 2024 | 313,974.00 |
| Jan 31, 2024 | 345,710.00 |
| Jan 31, 2024 | 345,710.00 |